Bill Commons

NY S 7987

in committee

Ensures continuity of care for cancer patients during insurance contract negotiations

New York · 2025-2026 Regular Session · upper

Quick answers

Did NY S 7987 pass?

Not yet. NY S 7987 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO INSURANCE

What is NY S 7987 about?

Ensures continuity of care for cancer patients during insurance contract negotiations by requiring insurance coverage and treatment continue until the conclusion of care.

Who sponsors NY S 7987?

Shelley Mayer is the primary sponsor of NY S 7987, joined by 4 cosponsors.

Description

Ensures continuity of care for cancer patients during insurance contract negotiations by requiring insurance coverage and treatment continue until the conclusion of care.

Introduced
Latest action
2026-01-07 — REFERRED TO INSURANCE
Bill type
bill
Last updated

Sponsors

  • Shelley Mayerprimary
  • Patricia Fahycosponsor
  • Pete Harckhamcosponsor
  • Gustavo Riveracosponsor
  • Toby Ann Staviskycosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-05-15

    REFERRED TO INSURANCE

    referral-committee

  2. 2025-08-08

    AMEND AND RECOMMIT TO INSURANCE

    amendment-passage,referral-committee

  3. 2025-08-08

    PRINT NUMBER 7987A

    amendment-passage

  4. 2026-01-07

    REFERRED TO INSURANCE

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 7987. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.